Familial hypertrophic cardiomyopathy in maine coon cats: An animal model of human disease

Circulation

Volumn 99, Issue 24, 1999, Pages 3172-3180

  Kittleson, Mark D ^a   Meurs, Kathryn M ^b   Munro, Marcia J ^e   Kittleson, Judith A ^a   Liu, Si Kwang ^c   Pion, Paul D ^a   Towbin, Jeffrey A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ANIMAL MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e University of California at Davis ^*

Author keywords

Cardiomyopathy; Genetics; Heart diseases; Hypertrophy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CAT; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HISTOPATHOLOGY; HOMOZYGOTE; HYPERTROPHIC CARDIOMYOPATHY; MITRAL VALVE; MUSCLE HYPERTROPHY; NONHUMAN; PEDIGREE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROGENY; STILLBIRTH;

EID: 0033594889     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.24.3172     Document Type: Article

References (30)

1. Bonne G, Carrier L, Richard P, Hainque B, Schwanz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res. 1998;83:580-593.
2. Tilley LP, Liu SK, Gilbertson SR, Wagner BM, Lord PF. Primary myocardial disease in the cat: a model for human cardiomyopathy. Am J Pathol. 1977;86:493-522.
3. Tilley LP, Liu S-K. Cardiomyopathy and thromboembolism in the cat. Feline Pract. 1975;5:32-37.
4. Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease. Circulation. 1995;92:2645-2651.
5. Liu SK, Maron BJ, Tilley LP. Feline hypertrophic cardiomyopathy: gross anatomic and quantitative histologic features. Am J Pathol. 1981;102: 388-395.
6. Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, Moses BL, Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med. 1993;7:247-252.
7. Maron BJ, Roberts WC. Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance. Am Heart J. 1981;102:95-110.
8. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1987;9:1013-1017.
9. Stalis IH, Bossbaly MJ, van Winkle TJ. Feline endomyocarditis and left ventricular endocardial fibrosis. Vet Pathol. 1995;32:122-126.
10. Bishop SP. Necropsy techniques for the heart and great vessels. In: Fox PR, ed. Canine and Feline Cardiology. New York, NY: Churchill Livingstone; 1988:637-640.
11. Liu SK. Postmortem examination of the heart. Vet Clin North Am. 1983;13:379-394.
12. Liu SK, Tilley LP. Animal models of primary myocardial diseases. Yale J Biol Med. 1980;53:191-211.
13. Thomas WP, Mathewson JW, Suter PF, Reed JR, Meierhenry EF. Hypertrophic obstructive cardiomyopathy in a dog: clinical, hemodynamic, angiographie, and pathologic studies. J Am Anim Hasp Assoc. 1984;20: 253-260.
14. Liu SK, Roberts WC, Maron BJ. Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs. Am J Cardiol. 1993;72:944-951.
15. Dai KS, Chen SP, Yang PC, Liu CY, Mao SJ. Ultrastructural alterations in pigs with naturally occurring hypertrophic cardiomyopathy. Br Vet J. 1995;152:333-338.
16. Huang SY, Tsou HL, Chiu YT, Shyu JJ, Wu JJ, Lin JH, Liu SK. Heritability estimate of hypertrophic cardiomyopathy in pigs (Sus scrofa domestica). Lab Anim Sci. 1996;46:310-314.
17. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation. 1994;89:22-32.
18. Schwanz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 1995;91:532-540.
19. Vosberg HP, McKenna WJ. Cardiomyopathies. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. New York, NY: Churchill Livingstone; 1996: 843-877.
20. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731-734.
21. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13: 63-69.
22. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614.
23. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation. 1992;85(suppl I):I-57-I-63.
24. Maron BJ, Isner JM, McKenna WJ. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol. 1994;24:880-885.
25. Capasso JM, Remily RM, Smith RH, Sonnenblick EH. Sex differences in myocardial contractility in the rat. Basic Res Cardiol. 1983;78:156-171.
26. Nishi H, Kimura A, Harada H, Adachi K, Koga Y, Sasazuki T, Toshima H. Possible gene dose effect of a mutant cardiac β-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochern Biophys Res Commun. 1994;200:549-556.
27. Jeschke B, Uhl K, Weist B, Schroeder D, Meitinger T, Doehlemann C, Vosberg HP. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes. Hum Genet. 1998;102:299-304.
28. Abchee A, Marian AJ. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Invest Med. 1997;45:191-196.
29. Tesson F, Dufour C, Moolman JC, Carrier L, al-Mahdawi S, Chojnowska L, Dubourg O, Soubrier E, Brink P, Komajda M, Guicheney P, Schwanz K, Feingold J. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol. 1997;29:831-838.
30. Maron BJ, Wolfson JK, Roberts WC. Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:785-790.